Is Better Standardization of Therapeutic Antibody Quality in Emerging Diseases Epidemics Possible?

During the ongoing COVID-19 epidemic many efforts have gone into the investigation of the SARS-CoV-2–specific antibodies as possible therapeutics. Currently, conclusions cannot be drawn due to the lack of standardization in antibody assessments. Here we describe an approach of establishing antibody...

Descripción completa

Detalles Bibliográficos
Autores principales: Ravlić, Sanda, Hećimović, Ana, Kurtović, Tihana, Ivančić Jelečki, Jelena, Forčić, Dubravko, Slović, Anamarija, Kurolt, Ivan Christian, Mačak Šafranko, Željka, Mušlin, Tatjana, Rnjak, Dina, Jakšić, Ozren, Sorić, Ena, Džepina, Gorana, Đaković Rode, Oktavija, Kujavec Šljivac, Kristina, Vuk, Tomislav, Jukić, Irena, Markotić, Alemka, Halassy, Beata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902244/
https://www.ncbi.nlm.nih.gov/pubmed/35273599
http://dx.doi.org/10.3389/fimmu.2022.816159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902244/
https://www.ncbi.nlm.nih.gov/pubmed/35273599
http://dx.doi.org/10.3389/fimmu.2022.816159

Ejemplares similares